Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Efawel
Efawel (Efavirenz Tablets 600 mg) is a highly effective antiretroviral medication used in the management of HIV-1 infection. As part of a combination therapy, it helps in suppressing viral replication, improving CD4 cell count, and slowing the progression of AIDS (Acquired Immunodeficiency Syndrome). Efawel is recommended as a first-line treatment due to its potent antiviral activity.
Uses of Efawel
Treatment of HIV-1 infection in adults and adolescents
Used as part of combination antiretroviral therapy (ART)
Helps in reducing viral load and increasing CD4 cell count
Delays the progression of HIV-related complications
Benefits of Efawel
Potent antiviral activity against HIV-1
Long half-life allows once-daily dosing for better compliance
Improves immune function and delays AIDS progression
Effectively reduces the risk of opportunistic infections
Can be used in both treatment-naïve and experienced patients
Mechanism of Action of Efawel
Efavirenz, the active ingredient in Efawel, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks the reverse transcriptase enzyme, an essential component for HIV replication. By preventing the virus from converting its RNA into DNA, Efawel reduces viral load and slows the progression of the disease.